Increased neuropeptide Y-like immunoreactivity in cerebrospinal fluid and plasma of human immunodeficiency virus-infected patients: Relationship to HIV encephalopathy

Journal of the Neurological Sciences

Volumn 136, Issue 1-2, 1996, Pages 154-158

  Malessa, Rolf ^a   Heimbach, Maja ^a   Brockmeyer, Norbert H ^a   Hengge, Ulrich ^a   Rascher, Wolfgang ^b   Michel, Martin C ^a  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

^b JUSTUS LIEBIG UNIVERSITY   (Germany)

Author keywords

Acquired immunodeficiency syndrome complication; Acquired immunodeficiency syndrome metabolism; AIDS dementia complex; Central nervous system physiopathology; HIV infections complications; Neuropeptide Y; Neuropeptides physiology; Prospective study

Indexed keywords

NEUROPEPTIDE Y; NORADRENALIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; BRAIN DISEASE; CEREBROSPINAL FLUID; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

EID: 0029874836     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/0022-510X(95)00305-L     Document Type: Article

References (23)

1. American Academy of Neurology AIDS Task Force (1991) Nomenclature and research case definitions for neurologic manifestations of human immunodeficiency virus-type 1 (HIV-1) infection. Neurology, 41: 778-785.
2. Brenneman, D.E., Westbrook, G.L., Fitzgerald, S.P., Ennist, D.L., Elkins, K.L., Ruff, M.R. and Pert, C.B. (1988) Neuronal cell killing by the envelope protein of HIV and its prevention by vasoactive intestinal peptide. Nature, 335: 639-642
3. Edvinsson, L., Minthon, L., Ekman, R. and Gustafson, L. (1993) Neuropeptides in cerebrospinal fluid of patients with Alzheimer's disease and dementia with frontotemporal lobe degeneration. Dementia, 4: 167-171.
4. Epstein, L.G. and Gendelman, H.E. (1993) Human immunodeficiency virus type 1 infection of the nervous system: pathogenetic mechanisms. Ann. Neurol., 33: 429-436.
5. Fleischer, B. (1994) CD26: a surface protease involved in T-cell activation. Immunol. Today., 15: 180-184.
6. Gjerris, A., Widerlöv, E., Werdelin, L. and Ekman, R. (1992) Cerebrospinal fluid concentrations of neuropeptide Y in depressed patients and in controls. J. Psychiatry Neurosci. 17: 23-27.
7. Gray, T.S. and Morley, J.E. (1986) Neuropeptide Y: anatomical distribution and possible function in mammalian nervous system. Life. Sci., 38: 389-401.
8. Grundemar, L. and Hakanson, R. (1994) Neuropeptide Y effector systems: perspectives for drug development. Trends Pharmacol. Sci., 15: 153-159.
9. Gutheil, W.G., Subramanyam, M., Flentke, G.R., et al. (1994) Human immunodeficiency virus 1 Tat binds to dipeptidyl aminopeptidase IV (CD26): a possible mechanism for Tat's immunosuppressive activity. Proc. Natl. Acad. Sci. USA, 91: 6594-6598.
10. Haninec, P. and Grim, M. (1990) Localization of dipetidylpeptidase IV and alkaline phosphatase in developing spinal cord meninges and peripheral nerve corverings or the rat. Int. J. Dev. Neurosci., 8: 175-185.
11. Heilig, M. and Widerlöv, E. (1990) Neuropeptide Y: an overview of central distribution, functional aspects, and possible involvement in neuropsychiatric illnesses. Acta Psychiatr. Scand., 82: 95-114.
12. Martignoni, E., Blandini, F., Petraglia, F., Pacchetti, C., Bono, G. and Nappi, G. (1992) Cerebrospinal fluid norepinephrine, 3-methox-4-hydroxyphenylglycol and neuropeptide Y levels in Parkinson's disease, multiple system atrophy and dementia of the Alzheimer type. J. Neural Transm., 4: 191-205.
13. Mentlein, R., Dahms, P., Grandt, D. and Krüger, R. (1993) Proteolytic processing of neuropeptide Y and peptide YY by dipeptidyl peptidase IV. Regul. Pept., 49: 133-144.
14. Michel, M.C. and Rascher, W. (1995) Neuropeptide Y: a possible role in hypertension? J. Hypertension, 13, 385-395.
15. Navia, B.A., Jordan, B.D. and Price, R.W. (1986) The AIDS dementia complex: I. Clinical features. Ann. Neurol., 19: 517-524.
16. Pernow, J., Lundberg, J.M. and Kaijser, L. (1987) Vasoconstrictor effects in vivo and plasma disappearance rate of neuropeptide Y in man. Life. Sci., 40: 47-54.
17. Price, R.W. and Brew, B.J. (1988) The AIDS dementia complex. J. Infect. Dis., 158: 1079-1083.
18. Price, R.W., Brew, B., Sidtis, J., Rosenblum, M., Scheck, A.C. and Cleary, P. (1988) The brain in AIDS: central nervous system HIV1 infection and AIDS dementia complex. Science, 239: 586-592.
19. Rascher, W., Kremens, B., Wagner, S., Feth, F., Hunneman, D.H. and Lang, R.E. (1993) Serial measurements of neuropeptide Y in plasma for monitoring neuroblastoma in children. J. Pediatr., 122: 914-916.
20. Rossi, M.E., Resti, M., Azzari, C., Calabri, G., De Martino, M., Galli, L., Carbonella, R. and Vierucci, A. (1994) High levels of IgA in HIV-1-perinatally-infected children. Antigen specificity and possible role of increased substance P plasma levels. Pediatr. Allergy Immunol. 5: 240-243.
21. Tatemoto, K., Carlquist, M. and Mutt, V. (1982) Neuropeptide Y - a novel brain peptide with structural similarities to peptide YY and pancreatic polypeptide. Nature, 296: 659-660.
22. + T lymphocytes of HIV-infected subjects. J. Acquir. Immune. Defic. Syndr., 6: 749-757.
23. Wahlestedt, C. and Reis, D.J. (1993) Neuropeptide Y-related peptides and their receptors - are the receptors potential therapeutic drug targets? Annu. Rev. Pharmacol. Toxicol., 32: 309-352.